CrowdStrike Holdings Trading Volume Drops 38.47% to $1.067 Billion Ranking 66th Despite 2.00% Stock Gain

On June 30, 2025, CrowdStrike Holdings (CRWD) experienced a significant decline in trading volume, with a turnover of $1.067 billion, marking a 38.47% decrease from the previous day. This placed CrowdStrike at the 66th position in terms of trading volume for the day. Despite this, the stock managed to close with a 2.00% gain.

CrowdStrike Holdings, Inc. (CRWD) recently filed a Form 144, disclosing a proposed sale of 553 common shares through Morgan Stanley Smith Barney LLC, valued at $282,030. The planned trade is scheduled for on or after June 30, 2025, on the NASDAQ. The filer, Roxanne S. Austin, has executed a series of insider sales within the past three months, totaling 47,188 shares and gross proceeds of approximately $22.3 million. This new notice represents only 0.0002% of CRWD’s reported 249,248,174 shares outstanding, a negligible proportion in liquidity terms. However, the cumulative selling activity may be monitored by investors who track insider sentiment. The filing also contains the standard Rule 144 representations stating that the seller is not aware of undisclosed material adverse information and, if applicable, operates under a Rule 10b5-1 trading plan.

CrowdStrike Holdings, Inc. (CRWD) has filed a Form 144, revealing a proposed sale of 553 common shares through Morgan Stanley Smith Barney LLC, valued at $282,030 based on market prices as of the filing. The planned trade is slated for on or after June 30, 2025, on the NASDAQ. The filer, Roxanne S. Austin, has previously executed a series of insider sales within the past three months, totaling 47,188 shares and gross proceeds of approximately $22.3 million. The new notice represents just 0.0002% of CRWD’s reported 249,248,174 shares outstanding, a negligible proportion in liquidity terms. Nevertheless, the cumulative selling activity may be monitored by investors who track insider sentiment. The filing also contains the standard Rule 144 representations stating that the seller is not aware of undisclosed material adverse information and, if applicable, operates under a Rule 10b5-1 trading plan.